Who owns Carmell Therapeutics Corp - US?
- Ticker: CTCXW
- CUSIP Number: 142922111
Tip: Access positions for across all investors
Analyze quarterly positions in Carmell Therapeutics Corp - US with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Carmell Therapeutics Corp - US stock
Who bought or sold Carmell Therapeutics Corp - US this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Antara Capital | 371k | $22k | 0% | Sep 2024 |
|
| Balyasny Asset Management | 343k | $25k | 0% | Jun 2024 |
|
| OZ Management | 228k | $20k | 0% | Sep 2024 |
|
| Highbridge Capital Management | 214k | $13k | 0% | Sep 2024 |
|
| CNH Partners | 80k | $4.8k | -1% | Sep 2024 |
|
| Exos Asset Management | 78k | $4.7M | -50% | Sep 2024 |
|
| Citadel Advisors | 75k | $4.5k | -1% | Sep 2024 |
|
| Saba Capital Management | 20k | $1.4k | 0% | Jun 2024 |
|
| Whitebox Advisors | 19k | $1.1k | 0% | Sep 2024 |
|
| Clear Street | 13k | $999.789200 | 0% | Jun 2024 |
|
| Ancora Advisors | 2.8k | $248.119900 | 0% | Sep 2024 |
|
| Wolverine Asset Management | 584.00 | $34.981600 | -87% | Sep 2024 |
|
| Bank of America Corporation | 100.00 | $6.000000 | 0% | Sep 2024 |
|
Who sold out of Carmell Therapeutics Corp - US?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Periscope Capital | Mar 2024 | 196k | $32k |
| Millennium Management | Jun 2024 | 189k | $14k |